"CHRISTUS St. Vincent Regional Cancer Center delivers compassionate, comprehensive, state-of-the-art care to cancer patients in Santa Fe, New Mexico."

During the past decade, Christus Saint Vincent Regional Cancer Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 17 clinical trials were completed, i.e. on average, 65.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 12 clinical trials were completed. i.e. 1200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Christus Saint Vincent Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "ImmunoVaccine Technologies, Inc. (IMV Inc.)" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christus Saint Vincent Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Christus Saint Vincent Regional Cancer Center" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage II Breast Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials) and "HER2/Neu Negative" (3 trials). Many other conditions were trialed in "Christus Saint Vincent Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Christus Saint Vincent Regional Cancer Center" are "Drug" (31 trials), "Other" (24 trials), "Biological" (11 trials), "Radiation" (10 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (8 trials), "Pembrolizumab" (6 trials), "Biospecimen Collection" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Christus Saint Vincent Regional Cancer Center" are 30 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Christus Saint Vincent Regional Cancer Center". undefined are not yet recruiting, 5 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Christus Saint Vincent Regional Cancer Center, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Christus Saint Vincent Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".